Mo Jain
Company: Sapient Bioanalytics
Job title: Founder & Chief Executive Officer
Seminars:
Next-Generation Multi-Omics to Identify Dynamic Biomarkers for Neurodegenerative Disease 2:00 pm
How next-generation mass spectrometry technologies are enabling large-scale, multi-omics biomarker discovery – including metabolites, lipids, and proteins Using precision-guided approaches for targeted multi-omic measures of established Alzheimer’s and Parkinson’s biomarkers Leveraging ‘discovery’ mass spectrometry to elucidate novel biomarkers of neurodegeneration and CNS drug responseRead more
day: Translational Track Day 2 PM